Related to TAP, Open University to Develop 3-D CNS Tissue Models for Research, Drug Testing

• Genzyme to Evaluate to-BBB’s Technology for Delivering Biologics to the Brain
  
• Developmental Delay May Stem from Nicotinic Receptor Deletion
  
• Evotec Awarded Roughly $3.74 by German Government to Hunt for Neuroprotective Compounds
  
• BioLife to Produce Custom Biopreservation Media for Centocor
  
• Lundbeck to Evaluate to-BBB's Technology for Delivering CNS-Disease Antibodies across the Blood-Brain Barrier
  
• Investigators Discover How Key Protein Leads to Neurodegenerative Diseases
  
• University of Florida Receives $15M, and Berkeley Lab Obtains $12.8M in ARRA Funding
  
• Corning and Sartorius Stedim Biotech to Provide Combined Cell-Culture Product Catalog
  
• Genentech and UCSF’s Small Molecule Discovery Center Ink Deal Targeting Neurodegenerative Diseases
  
• Biovail to Pay Cortex $10M for Ampakine Compounds against Respiratory Depression
  
• Evotec Wins €1.5M in German Federal Funding to Take H3 Receptor Blocker into Clinic
  
• SAFC to Invest $6.25M to Fortify Kansas Facility
  
• AstraZeneca to Pay $520M Settlement in Seroquel Lawsuit
  
• Australian Government Commissions DSM to Build Biomanufacturing Facility
  
• TPP Raises £9.6M to Build Preclinical Pipeline
  
• Santhera Shares Drop 35% as Friedreich Ataxia Drug Fails in Phase III
  
• NeuroTherapeutics Scores $43M in Series B Financing Round
  
• Pharnext Raises €4.8M to Progress Pipeline of Repositioned Drugs
  
• FoldRx Raises $29M to Fund Progression of Lead ATTR-PN Candidate to Market
  
• Lonza Negotiates License to Axxam’s Photoproteins for Clonetics Primary Sensor Cells